These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14745125)

  • 1. [Effects of humoral factors on left ventricular remodeling under chronic heart failure].
    Kodama M; Tachikawa H; Kashimura T; Hayashi M; Yoshida T; Hanawa H; Aizawa Y; Nakazawa M; Watanabe K
    Nihon Yakurigaku Zasshi; 2004 Feb; 123(2):63-70. PubMed ID: 14745125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
    Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Hypertens Res; 2010 Jul; 33(7):695-702. PubMed ID: 20535115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis.
    Watanabe K; Sukumaran V; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Arozal W; Sari FR; Lakshmanan AP; Arumugam S; Soetikno V; Rajavel V; Suzuki K
    Inflamm Allergy Drug Targets; 2011 Jun; 10(3):218-25. PubMed ID: 21495969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined selective angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats.
    Richer C; Gervais M; Fornes P; Giudicelli JF
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):772-81. PubMed ID: 10598119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure.
    Fujii M; Wada A; Ohnishi M; Tsutamoto T; Matsumoto T; Yamamoto T; Takayama T; Dohke T; Isono T; Eguchi Y; Horie M
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S346-9. PubMed ID: 15838317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
    Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1338-46. PubMed ID: 20876084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure.
    Wakisaka Y; Niwano S; Niwano H; Saito J; Yoshida T; Hirasawa S; Kawada H; Izumi T
    Cardiovasc Res; 2004 Sep; 63(4):689-99. PubMed ID: 15306225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW; Huang YW; Xia Q; Xu QW
    Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
    Tachikawa H; Kodama M; Watanabe K; Takahashi T; Ma M; Kashimura T; Ito M; Hirono S; Okura Y; Kato K; Hanawa H; Aizawa Y
    Circulation; 2005 Feb; 111(7):894-9. PubMed ID: 15710769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of imidapril and TA-606 on rat dilated cardiomyopathy after myocarditis.
    Kashimura T; Hayashi M; Kodama M; Nakazawa M; Abe S; Yoshida T; Tachikawa H; Hanawa H; Kato K; Watanabe K; Aizawa Y
    Jpn Heart J; 2003 Sep; 44(5):735-44. PubMed ID: 14587655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
    Mulder P; Boujedaini H; Richard V; Henry JP; Renet S; Münter K; Thuillez C
    Circulation; 2002 Aug; 106(9):1159-64. PubMed ID: 12196345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA therapy against carbohydrate sulfotransferase 15 inhibits cardiac remodeling in rats with dilated cardiomyopathy.
    Watanabe K; Arumugam S; Sreedhar R; Thandavarayan RA; Nakamura T; Nakamura M; Harima M; Yoneyama H; Suzuki K
    Cell Signal; 2015 Jul; 27(7):1517-24. PubMed ID: 25778904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies.
    Takano H; Hasegawa H; Nagai T; Komuro I
    Intern Med; 2003 Jun; 42(6):465-9. PubMed ID: 12857042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
    Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
    Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
    Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
    Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
    Tachikawa H; Kodama M; Hui L; Yoshida T; Hayashi M; Abe S; Kashimura T; Kato K; Hanawa H; Watanabe K; Nakazawa M; Aizawa Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure.
    Yamamoto K; Mano T; Yoshida J; Sakata Y; Nishikawa N; Nishio M; Ohtani T; Hori M; Miwa T; Masuyama T
    J Hypertens; 2005 Feb; 23(2):393-400. PubMed ID: 15662228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.